549 related articles for article (PubMed ID: 33516862)
1. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
2. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
[TBL] [Abstract][Full Text] [Related]
4. Sphenoid Wing Meningiomas: Surgical Outcomes in a Series of 141 Cases and Proposal of a Scoring System Predicting Extent of Resection.
Güdük M; Özduman K; Pamir MN
World Neurosurg; 2019 May; 125():e48-e59. PubMed ID: 30639480
[TBL] [Abstract][Full Text] [Related]
5. Neurosurgical follow-up and treatment of a series of 26 WHO grade III meningiomas.
Güdük M; Ekşi MŞ; Bozkurt B; Usseli Mİ; Erşen Danyeli A; Pamir MN
J Clin Neurosci; 2021 Sep; 91():219-225. PubMed ID: 34373031
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
7. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
8. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Jecko V
Neurochirurgie; 2016 Aug; 62(4):203-8. PubMed ID: 27339832
[TBL] [Abstract][Full Text] [Related]
10. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.
Hwang WL; Marciscano AE; Niemierko A; Kim DW; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Loeffler JS; Oh KS; Shih HA; Larvie M
Neuro Oncol; 2016 Jun; 18(6):863-72. PubMed ID: 26597949
[TBL] [Abstract][Full Text] [Related]
11. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Gallagher MJ; Jenkinson MD; Brodbelt AR; Mills SJ; Chavredakis E
Clin Neurol Neurosurg; 2016 Feb; 141():117-21. PubMed ID: 26780494
[TBL] [Abstract][Full Text] [Related]
12. Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma?
Schipmann S; Schwake M; Sporns PB; Voß KM; Sicking J; Spille DC; Hess K; Paulus W; Stummer W; Brokinkel B
World Neurosurg; 2018 Nov; 119():e589-e597. PubMed ID: 30081236
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and management differences for grade II and III spinal meningiomas.
Krauss WE; Yolcu YU; Alvi MA; Moinuddin FM; Goyal A; Clarke MJ; Marsh WR; Bydon M
J Neurooncol; 2021 Jun; 153(2):313-320. PubMed ID: 33973145
[TBL] [Abstract][Full Text] [Related]
15. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
18. The Simpson grading: defining the optimal threshold for gross total resection in meningioma surgery.
Brokinkel B; Spille DC; Brokinkel C; Hess K; Paulus W; Bormann E; Stummer W
Neurosurg Rev; 2021 Jun; 44(3):1713-1720. PubMed ID: 32809081
[TBL] [Abstract][Full Text] [Related]
19. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
[TBL] [Abstract][Full Text] [Related]
20. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
